Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1110065Generated: October 25, 2026

3-Methyl-2-butenoic acid → Dihydrocoumarin

https://huagongshe.com/reaction/1110065

Reaction equation

Participants

RoleNameHCIDCharge
Reactant3-Methyl-2-butenoic acidHCID 10931—
Reactant3-BromophenolHCID 11563—
ReactantSodium hydrideHCID 24758—
ReactantPhenyl acrylateHCID 61242—
CatalystAluminum(III) ChlorideHCID 6451240—
SolventDichloromethaneHCID 6344—
SolventTetrahydrofuranHCID 8028—
ProductDihydrocoumarinHCID 660—
Product7-Bromochroman-2-oneHCID 20083251—

Reaction Steps

Thus, in accordance with Reaction Scheme 6, 3-bromo phenol, or a 3-bromo phenol substituted in the 4 (para) position by an alkyl substituent (Compound 7) is acylated with an acylating agent, such as the acid chloride (Compound 11) derived from 3,3-dimethylacrylic acid or from another appropriately substituted acrylic acid (R1 ' and R2 ' is either H or lower alkyl). The acylation of the 3-bromo-phenol (Compound 7) with the acid chloride (Compound 11) is preferably conducted in the presence of a strong base (e.g. sodium hydride) in an inert solvent (such as tetrahydrofuran). The resulting phenyl-acrylate (Compound 12) is ring closed under Friedel-Crafts type reaction conditions (e.g. AlCl3 catalyst, in an inert solvent such as methylene chloride) to provide two positional isomers (Compound 13) and (Compound 14) of the 2-oxo-chroman derivative, each of which bears, in the 4-position, the CH2R1 ' and CH2R2 ' substituents and where R5 is hydrogen or lower alkyl. As described previously for Reaction Scheme 5, the mixture is then separated by conventional means to obtain the desired 7-bromo-2-oxo-chroman (Compound 13). It should be noted that as also described previously in connection with Reaction Scheme 5 the 7-bromo-2-oxo chroman (Compound 13) can be separated from the potential regio-isomeric impurities at the carboxylic acid stage or at the final coupling stage. The 2-oxo-7-bromo-chroman (Compound 13) is thereafter reduced with lithium aluminum hydride or an appropriate reducing agent to provide the 7-bromo-diol (Compound 15). The diol (Compound 15) is then mono-mesylated at the primary alcohol position followed by intramolecular nucleophilic displacement of a mesyl leaving group, to give the 7-bromo-chroman (Compound 8) which bears the desired CH2 -R1 ', CH2R2 ' and R5 substituents. The carboxylic acid function is introduced into the 7-position in the same manner as described previously in Reaction Scheme 5 to give the 7-carboxy chroman (Compound 10).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05324744
Source datasetuspto-grants-1994_06
ORD IDord-36c2817fd6c64314abfe6a7ff0cf721f
Source noteuspto-grants-1994_06